Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.085
-0.105 (-3.29%)
Sep 15, 2026, 12:50 PM EDT - Market open
Voyager Therapeutics Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Voyager Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $14.89. The average 1-year stock price forecast is 382.66% higher than the current stock price, while the lowest is $8.00 (+159.32%) and the highest is $25 (+710.37%).
Price Target: $14.89 (+382.66%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Voyager Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 11 | 11 | 11 | 11 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $25 | Buy | Reiterates | $25 | +710.37% | Aug 27, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $12 | Buy | Reiterates | $12 | +288.98% | Aug 13, 2026 |
| Wedbush | Wedbush | Buy Maintains $8 | Buy | Maintains | $8 | +159.32% | Aug 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $22 | Buy | Maintains | $22 | +613.13% | Jun 2, 2026 |
Financial Forecast
Revenue This Year
20.28M
from 40.37M
Decreased by -49.78%
Revenue Next Year
46.58M
from 20.28M
Increased by 129.75%
EPS This Year
-1.70
from -2.04
EPS Next Year
-1.28
from -1.70
EPS and Forward PE are based on non-GAAP adjusted numbers.